{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-272710","form_type":"8-K","ticker":"ORGO","cik":"0001661181","company_name":"Organogenesis Holdings Inc.","filed_at":"2026-06-16T20:32:55+00:00","discovered_at":"2026-06-16T20:34:00.380924+00:00","generated_at":"2026-06-16T20:34:38.981704+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Organogenesis shareholders elect 9 directors, approve say-on-pay and auditor at annual meeting","bullets":["All 9 director nominees elected; Glenn H. Nussdorf received lowest support (61M for, 24.3M withheld).","Advisory say-on-pay approved with 72.5M for, 12.7M against, 61k abstentions.","Ratification of RSM US LLP as auditor for FY2026 approved with 128.4M votes for.","Series A Preferred holders re-elected Garrett Lustig to board via written consent.","129.6M shares present or represented at the June 15, 2026 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-272710","json":"https://secwatch.observer/filing/0001193125-26-272710.json","markdown":"https://secwatch.observer/filing/0001193125-26-272710.md","text":"https://secwatch.observer/filing/0001193125-26-272710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661181/000119312526272710/0001193125-26-272710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661181/000119312526272710/d66140d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T20:34:38.981704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f6befce80fbdba475c9fe0e84d6b66802e5971b","claim":"Organogenesis Holdings Inc. shareholders approved To approve, on an advisory basis, the compensation paid to our named executive officers. at the 2026-06-15 meeting.","evidence_excerpt":"At the Annual Meeting, our stockholders also approved, on an advisory basis, the compensation paid to our named executive officers. The votes cast on this proposal were as follows: Proposal Votes For Votes Against Abstentions Broker Non-Votes To approve, on an advisory basis, the compensation paid to our named executive officers. 72,516,011 12,722,258 61,328 44,264,824","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312526272710/0001193125-26-272710-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"207399e29c9fb9737c9a19081e835fbba6e86e5b","claim":"Organogenesis Holdings Inc. shareholders approved Election of Directors at the 2026-06-15 meeting.","evidence_excerpt":"At the Annual Meeting, each of Robert Ades, Michael J. Driscoll, Prathyusha Duraibabu, Jon Giacomin, Gary S. Gillheeney, Sr., Michele Korfin, Arthur S. Leibowitz, Glenn H. Nussdorf and Gilberto Quintero was elected our Director, to serve until the next Annual Meeting of Stockholders and until their successors are elected and qualified. The votes cast in the election of the directors were as follows: Nominee Votes For Votes Withheld Broker Non-Votes Robert Ades 85,064,304 235,293 44,264,824 Michael J. Driscoll 76,582,548 8,717,049 44,264,824 Prathyusha Duraibabu 76,767,319 8,532,278 44,264,824 Jon Giacomin 64,825,495 20,474,102 44,264,824 Gary S. Gillheeney, Sr. 76,736,718 8,562,879 44,264,824 Michele Korfin 76,707,741 8,591,856 44,264,824 Arthur S. Leibowitz 76,682,590 8,617,007 44,264,824 Glenn H. Nussdorf 61,049,018 24,250,579 44,264,824 Gilberto Quintero 76,572,688 8,726,909 44,264,824","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312526272710/0001193125-26-272710-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"6186ecb5f3ed5e090097320440a6373a5a7a59e3","claim":"Organogenesis Holdings Inc. shareholders approved To ratify the appointment of RSM US LLP as our independent registered public accounting firm for fiscal year 2026. at the 2026-06-15 meeting.","evidence_excerpt":"At the Annual Meeting, our stockholders also approved the proposal to ratify the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending on December 31, 2026. The votes cast on this proposal were as follows: Proposal Votes For Votes Against Abstentions Broker Non-Votes To ratify the appointment of RSM US LLP as our independent registered public accounting firm for fiscal year 2026. 128,421,160 856,933 286,328 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312526272710/0001193125-26-272710-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}